Vladimir Temchura

14PUBLICATIONS
14CO-AUTHORS
NanomaterialsNanotoxicology, health and safetyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 07, 2026
Silica-coated papillomavirus-based nanoparticles: a shielded scaffold for HIV-1 vaccines.

|Jan 23, 2024
Immunogenicity of Recombinant Lipid-Based Nanoparticle Vaccines: Danger Signal vs. Helping Hand.

Vladimir Temchura, Jannik T Wagner, Dominik Damm

|Jul 27, 2022
Inhibitors of Deubiquitinating Enzymes Interfere with the SARS-CoV-2 Papain-like Protease and Block Virus Replication In Vitro.

Maximilian Große, Christian Setz, Pia Rauch

|Jul 27, 2022
Design and Functional Characterization of HIV-1 Envelope Protein-Coupled T Helper Liposomes.

Dominik Damm, Ehsan Suleiman, Hannah Theobald

|Apr 03, 2021
Decorated and Encapsulated: Virus-Like Particles Against Viral Infections.

Vladimir Temchura

|Oct 17, 2020
CD4+ T Cells Induced by Tuberculosis Subunit Vaccine H1 Can Improve the HIV-1 Env Humoral Response by Intrastructural Help.

Stephan Klessing, Vladimir Temchura, Pierre Tannig

Pageof 3

Frequent Collaborators

2 joint publications

Matthias Epple

2 joint publications

Karola Vorauer-Uhl

2 joint publications

Matthias Tenbusch

2 joint publications

Klaus Überla